Bruce D. Smith | AMiner学者主页

订阅小程序

旧版功能

开通会员低至0.73元/天

一次搞定AI科研

立即登录

English

联系方式

全面呈现 [Bruce D. Smith] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

论文（1）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1Phase I Trial of Alpha-Particle Immunotherapy with Ac-225-Lintuzumab and Low-Dose Cytarabine in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia.

Joseph Jurcic,Moshe Levy,Jae Park,Farhad Ravandi,Alexander Perl,John Pagel,B. Smith,Johnnie Orozco,Elihu Estey,Hagop Kantarjian,Dragan Cicic,David Scheinberg

2017JOURNAL OF NUCLEAR MEDICINE（2017）引用：24

引用

AI阅读

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

Dragan Cicic合作论文数1

Moshe Y Levy合作论文数1

Hagop M. Kantarjian合作论文数Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center1

Park Jae H合作论文数1

Orozco Johnnie J合作论文数1

John Maher合作论文数School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King’s College London1

Elihu H. Estey合作论文数Division of Hematology & Oncology, University of Washington1

Alexander Edward Perl合作论文数Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania;Institute for Translational Medicine and Therapeutics, University of Pennsylvania;Hospital of the University of Pennsylvania1

Farhad Ravandi-Kashani合作论文数Section of Developmental Therapeutics, Department of Leukemia, The University of Texas MD Anderson Cancer Center;Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center1

Joseph G. Jurcic合作论文数1

David Scheinberg合作论文数Graduate School of Medical Sciences, Weill Cornell Medicine;Weill Cornell Medical College;The David Scheinberg Lab, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center;Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center1

相似学者

Alexander Edward Perl

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn